TILs in Solid Tumors
With the FDA’s approval of the first tumor‑infiltrating lymphocyte (TIL) therapy to treat advanced melanoma, researchers seek to expand this type of cellular therapy to other solid tumors.
With the FDA’s approval of the first tumor‑infiltrating lymphocyte (TIL) therapy to treat advanced melanoma, researchers seek to expand this type of cellular therapy to other solid tumors.
The drug showed promise in treating small cell lung cancer that had progressed during or after chemotherapy.
Acupuncture helps manage side effects of endocrine therapy, and adding chemotherapy before surgery delays progression in pancreatic cancer.
Learn about cancer vaccines, including the various types used to treat or prevent cancer, and discover what's on the horizon.
The June edition of Editors’ Picks includes a clinical trial that clinched a new FDA approval for adagrasib, a new imaging modality to predict glioblastoma response, and more.
Patients given waivers to participate in A trial had outcomes the same or slightly better than people who met the standard requirements; findings support broader and more inclusive trial designs. Cancer patients sometimes find...
The FDA approved the immunotherapy epcoritamab-bysp for certain patients with follicular lymphoma. The U.S. Food and Drug Administration (FDA) has granted accelerated approval to epcoritamab-bysp (Epkinly) for the treatment of adult patients with follicular...
The FDA issued its first approval for the use of A KRAS G12C inhibitor in a tumor type other than lung. The U.S. Food and Drug Administration (FDA) has granted accelerated approval to adagrasib...
Risk for cancer and cardiovascular disease linked to air pollution, and three cancer drugs could face generic competition by 2028.
Learn about the types of cancer immunotherapy including immune checkpoint inhibitors, ACT, therapeutic vaccines, and more.